Caplin Point Labs Arm Gets USFDA Approval for Timolol Maleate; Shares Drop 7%
Shares of Caplin Point Laboratories Ltd. dropped 7% after touching a day’s high of Rs 1,611.80 on 8th August, despite the company’s subsidiary receiving final...
Tag : US Food and Drug Administration (USFDA)
Alembic Pharma Secures USFDA Approval for Cancer Drug; Shares Gain 3%
Shares of Alembic Pharmaceuticals Ltd were trading in the green and 3% higher on 2 August after the company announced securing final approval from the...
Sun Pharma Receives USFDA Approval for Alopecia Treatment Drug; Shares Jump 3%
Shares of Sun Pharmaceutical Industries Ltd. surged by almost 3% to touch a day’s high of Rs 1,712.40 on 26 July after announcing USFDA approval...
Gland Pharma Shares Slip 2% as USFDA Issued 2 Observations
Shares of Gland Pharma Ltd slipped 2% and hit an intra-day low of Rs 1,978.40 on 25 July after the company announced that the US...
Jubilant Pharmova Shares Slump 4% as Canada Facility Receives VAI Status from USFDA
Shares of Jubilant Pharmova slumped 4% on 22 July after the company’s Canada plant as having a “voluntary action indicated” (VAI) status by the US...
Zydus Lifesciences Shares Slumped 3% as Jarod Unit Received OAI Classification
Shares of Zydus Lifesciences were trading in the red and 3% lower on 19 July after the company announced that its Jarod unit received OAI...
Glenmark Receives USFDA Final Approval for Topiramate Capsules
Glenmark Pharmaceuticals has received final approval from the United States Food & Drug Administration (USFDA) for its Topiramate Capsules USP, 15 mg and 25 mg,...
Lupin Shares Rise 2% on USFDA EIR for Dabhasa Facility
Shares of Lupin Ltd. surged by almost 2% to a day’s high of Rs 1838.15 on 15 July after the company secured the Establishment Inspection...
Alembic Pharma Shares Surge on USFDA Tentative Approval for Selexipag Injection
Shares of Alembic Pharmaceuticals rose by almost 2% to a day’s high of Rs 996.35 on 15 July, after the company received a tentative USFDA...
Zydus Lifesciences Shares Hit 52-Week High on Securing USFDA Approval
Shares of Zydus Lifesciences hit a 52-week high of Rs 1,203 on 11 July after the company announced that the US Food and Drug Administration...